{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:33:49Z","timestamp":1790087629676,"version":"4.0.1"},"reference-count":17,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.5551\/jat.50518","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T18:04:37Z","timestamp":1568743477000},"page":"449-460","source":"Crossref","is-referenced-by-count":7,"title":["Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS"],"prefix":"10.5551","volume":"27","author":[{"given":"Naohisa","family":"Hosomi","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Women's Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Nagai","sequence":"additional","affiliation":[{"name":"Center for Clinical Research, Kobe University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Division of Medical Statistics, Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Nezu","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kagimura","sequence":"additional","affiliation":[{"name":"Division of Medical Statistics, Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Origasa","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Minematsu","sequence":"additional","affiliation":[{"name":"National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Clinical Research Center, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences"},{"name":"Sakai City Medical Center, Sakai City Hospital Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for J-STARS collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A, 3rd, Hennerici M, Simunovic L, Zivin JA, Welch KM and Investigators S: Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke, 2007; 38: 3198-3204","DOI":"10.1161\/STROKEAHA.107.493106"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM and Stroke Prevention by Aggressive Reduction in Cholesterol Levels I: Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke, 2008; 39: 3297-3302","DOI":"10.1161\/STROKEAHA.108.516450"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Amarenco P, Benavente O, Goldstein LB, Callahan A, 3rd, Sillesen H, Hennerici MG, Gilbert S, Rudolph AE, Simunovic L, Zivin JA and Welch KM: Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke, 2009; 40: 1405-1409","DOI":"10.1161\/STROKEAHA.108.534107"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M and J-STARS collaborators: Cumulative effects of LDL cholesterol and CRP levels on recurrent stroke and TIA. J Atheroscler Thromb, 2018 in press;","DOI":"10.5551\/jat.45989"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M and J-STARS Investigators: Reduction in high-sensitivity C-reactive protein levels in patients with ischemic stroke by statin treatment: Hs-CRP Sub-Study in J-STARS. J Atheroscler Thromb, 2017; 24: 1039-1047","DOI":"10.5551\/jat.39354"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M and J-STARS Collaborators: Desirable low-density lipoprotein cholesterol levels for preventing stroke recurrence: a post hoc analysis of the J-STARS Study. Stroke, 2018; 49: 865-871","DOI":"10.1161\/STROKEAHA.117.018870"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nagai Y, Kohriyama T, Origasa H, Minematsu K, Yokota C, Uchiyama S, Ibayashi S, Terayama Y, Takagi M, Kitagawa K, Nomura E, Hosomi N, Ohtsuki T, Yamawaki T, Matsubara Y, Nakamura M, Yamasaki Y, Mori E, Fukushima M, Kobayashi S, Shinohara Y, Yamaguchi T, Matsumoto M and Investigators J-S: Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS). Int J Stroke, 2014; 9: 232-239","DOI":"10.1111\/ijs.12099"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M and J-STARS collaborators: The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, openlabel, parallel-group study. EBioMedicine, 2015; 2: 1071-1078","DOI":"10.1016\/j.ebiom.2015.08.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M and Kiyohara Y: LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke, 2009; 40: 382-388","DOI":"10.1161\/STROKEAHA.108.529537"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M and J-STARS Investigators: Long-term effect of pravastatin on carotid intima-media complex thickness: The J-STARS Echo Study. Stroke, 2018; 49: 107-113","DOI":"10.1161\/STROKEAHA.117.018387"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Collins R, Armitage J, Parish S, Sleight P, Peto R and Heart Protection Study Collaborative Group: Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet, 2004; 363: 757-767","DOI":"10.1016\/S0140-6736(04)15690-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Goldstein LB, Amarenco P, Szarek M, Callahan A, 3rd, Hennerici M, Sillesen H, Zivin JA, Welch KM and Investigators S: Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology, 2008; 70: 2364-2370","DOI":"10.1212\/01.wnl.0000296277.63350.77"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bezerra DC, Sharrett AR, Matsushita K, Gottesman RF, Shibata D, Mosley TH, Jr., Coresh J, Szklo M, Carvalho MS and Selvin E: Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology, 2012; 78: 102-108","DOI":"10.1212\/WNL.0b013e31823efc42"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Matz K, Tatschl C, Sebek K, Dachenhausen A and Brainin M: Dyslipidemia, elevated LDL cholesterol and reduced nocturnal blood pressure dipping denote lacunar strokes occurring during nighttime. Eur J Neurol, 2004; 11: 742-748","DOI":"10.1111\/j.1468-1331.2004.00811.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Moran C, Phan TG and Srikanth VK: Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke, 2012; 7: 36-46","DOI":"10.1111\/j.1747-4949.2011.00725.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Montagne A, Nikolakopoulou AM, Zhao Z, Sagare AP, Si G, Lazic D, Barnes SR, Daianu M, Ramanathan A, Go A, Lawson EJ, Wang Y, Mack WJ, Thompson PM, Schneider JA, Varkey J, Langen R, Mullins E, Jacobs RE and Zlokovic BV: Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med, 2018; 24: 326-337","DOI":"10.1038\/nm.4482"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Boucher K, Siegel CS, Sharma P, Hauschka PV and Solomon KR: HMG-CoA reductase inhibitors induce apopto sis in pericytes. Microvasc Res, 2006; 71: 91-102","DOI":"10.1016\/j.mvr.2005.11.007"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/5\/27_50518\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T03:03:47Z","timestamp":1588820627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/5\/27_50518\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.50518","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}